Y. Vanrenterghem

发表

Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients.

D. Kuypers, H. de Jonge, M. Naesens, 2008, Clinical Therapeutics.

Intrarenal resistive index after renal transplantation.

E. Lerut, B. Bammens, R. Oyen, 2013, The New England journal of medicine.

p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

K. Verbeke, B. Bammens, H. de Loor, 2009, Clinical journal of the American Society of Nephrology : CJASN.

p-Cresol and cardiovascular risk in mild-to-moderate kidney disease.

K. Verbeke, B. Bammens, D. Kuypers, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.

K. Verbeke, B. Bammens, Y. Vanrenterghem, 2006, Kidney international.

Long‐Term Changes in Mycophenolic Acid Exposure in Combination with Tacrolimus and Corticosteroids Are Dose Dependent and Not Reflected by Trough Plasma Concentration: A Prospective Study in 100 De Novo Renal Allograft Recipients

B. Maes, D. Kuypers, Y. Vanrenterghem, 2003, Journal of clinical pharmacology.

Clinical Efficacy and Toxicity Profile of Tacrolimus and Mycophenolic Acid in Relation to Combined Long‐term Pharmacokinetics in de Novo Renal Allograft Recipients

B. Maes, D. Kuypers, Y. Vanrenterghem, 2004, Clinical pharmacology and therapeutics.

Multidrug Resistance Protein 2 Genetic Polymorphisms Influence Mycophenolic Acid Exposure in Renal Allograft Recipients

K. Verbeke, D. Kuypers, M. Naesens, 2006, Transplantation.

Influenza Vaccination Is Efficacious and Safe in Renal Transplant Recipients

A. Osterhaus, B. Maes, B. Bammens, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection.

F. Oppenheimer, Y. Vanrenterghem, R. Hené, 2000, Transplantation.

The predictive value of kidney allograft baseline biopsies for long-term graft survival.

E. Lerut, D. Kuypers, M. Naesens, 2013, Journal of the American Society of Nephrology : JASN.

Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis.

K. Verbeke, B. Bammens, Y. Vanrenterghem, 2006, Kidney international.

Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism.

D. Kuypers, H. de Jonge, H. de Loor, 2013, Pharmacogenomics.

Functional &bgr;-Cell Mass and Insulin Sensitivity Is Decreased in Insulin-Independent Pancreas-Kidney Recipients

C. Mathieu, B. Maes, D. Pipeleers, 2009, Transplantation.

Evidence for impaired assimilation of protein in chronic renal failure.

K. Verbeke, B. Bammens, Y. Vanrenterghem, 2003, Kidney international.

The Impact of Renal Allograft Function on Exposure and Elimination of Mycophenolic Acid (MPA) and Its Metabolite MPA 7-O-glucuronide

D. Kuypers, M. Naesens, H. de Loor, 2007, Transplantation.

CYP3A5 and CYP3A4 but not MDR1 Single‐nucleotide Polymorphisms Determine Long‐term Tacrolimus Disposition and Drug‐related Nephrotoxicity in Renal Recipients

E. Lerut, D. Kuypers, Y. Vanrenterghem, 2007, Clinical pharmacology and therapeutics.

Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients

D. Kuypers, H. de Jonge, M. Naesens, 2008, Pharmacogenetics and genomics.

THE RATE OF GASTRIC EMPTYING DETERMINES THE TIMING BUT NOT THE EXTENT OF ORAL TACROLIMUS ABSORPTION: SIMULTANEOUS MEASUREMENT OF DRUG EXPOSURE AND GASTRIC EMPTYING BY CARBON-14-OCTANOIC ACID BREATH TEST IN STABLE RENAL ALLOGRAFT RECIPIENTS

B. Maes, D. Kuypers, Y. Vanrenterghem, 2004, Drug Metabolism and Disposition.

Reduced C0 Concentrations and Increased Dose Requirements in Renal Allograft Recipients Converted to the Novel Once-Daily Tacrolimus Formulation

K. Verbeke, D. Kuypers, H. de Jonge, 2010, Transplantation.

Correlation between Oxidized Low Density Lipoproteins and von Willebrand Factor in Chronic Renal Failure

E. Lesaffre, Y. Vanrenterghem, J. Arnout, 1996, Thrombosis and Haemostasis.

p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin.

K. Verbeke, V. De Preter, Y. Vanrenterghem, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Chronic Histological Damage in Early Indication Biopsies Is an Independent Risk Factor for Late Renal Allograft Failure

E. Lerut, B. Bammens, D. Kuypers, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.

K. Verbeke, B. Bammens, D. Kuypers, 2013, Clinical journal of the American Society of Nephrology : CJASN.

In Vivo CYP3A Activity Is Significantly Lower in Cyclosporine‐Treated as Compared With Tacrolimus‐Treated Renal Allograft Recipients

K. Verbeke, D. Kuypers, Y. Vanrenterghem, 2011, Clinical pharmacology and therapeutics.

Reduction in Protein-Bound Solutes Unacceptable as Marker of Dialysis Efficacy during Alternate-Night Nocturnal Hemodialysis

T. Meyer, P. Kerr, K. Verbeke, 2011, American Journal of Nephrology.

Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.

D. Vanderschueren, B. Bammens, D. Kuypers, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.

B. Bammens, D. Kuypers, H. de Jonge, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Measuring total blood calcium displays a low sensitivity for the diagnosis of hypercalcemia in incident renal transplant recipients.

B. Bammens, D. Kuypers, Y. Vanrenterghem, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Aortic calcifications and arterial stiffness as predictors of cardiovascular events in incident renal transplant recipients

B. Bammens, D. Kuypers, M. Naesens, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.

K. Verbeke, B. Bammens, Y. Vanrenterghem, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms.

K. Verbeke, B. Bammens, Y. Vanrenterghem, 2003, Kidney international.

IgA antiglomerular basement membrane disease associated with bronchial carcinoma and monoclonal gammopathy.

B. Maes, D. Kuypers, Y. Vanrenterghem, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Serum Concentrations of p-Cresyl Sulfate and Indoxyl Sulfate, but Not Inflammatory Markers, Increase in Incident Peritoneal Dialysis Patients in Parallel with Loss of Residual Renal Function

B. Bammens, Y. Vanrenterghem, B. Meijers, 2014, Peritoneal Dialysis International.

Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients.

D. Vanderschueren, B. Bammens, Y. Vanrenterghem, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study.

K. Verbeke, B. Bammens, Y. Vanrenterghem, 2006, Kidney international.

Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for Transplantation.

B. Maes, Y. Vanrenterghem, J. Pirenne, 1998, Transplantation.

Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure.

P. Flamen, B. Maes, S. Segaert, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A Prospective, Randomized, Double-Blind Crossover Study on the Use of 5% Citrate Lock versus 10% Citrate Lock in Permanent Hemodialysis Catheters

B. Maes, D. Kuypers, Y. Vanrenterghem, 2005, Blood Purification.

The management of the failed renal allograft.

Y. Vanrenterghem, S. Khamis, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).

B. Bammens, D. Kuypers, Y. Vanrenterghem, 2008, Nephrology, Dialysis and Transplantation.

POST-STREPTOCOCCAL GLOMERULONEPHRITIS: NOT AN EXTINCT DISEASE!

E. Lerut, B. Bammens, D. Kuypers, 2013, Acta clinica Belgica.

Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept.

K. Verbeke, B. Bammens, Y. Vanrenterghem, 2004, The American journal of clinical nutrition.

Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem.

D. Kuypers, Y. Vanrenterghem, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group.

C. Bulpitt, J. Staessen, A. Amery, 1992, The New England journal of medicine.

Troponin I Is a Predictor of Acute Cardiac Events in the Immediate Postoperative Renal Transplant Period

B. Bammens, D. Kuypers, Y. Vanrenterghem, 2010, Transplantation.

The uremic retention solute p-cresyl sulfate and markers of endothelial damage.

W. Dehaen, K. Verbeke, M. Hoylaerts, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Calcium metabolism in the early posttransplantation period.

B. Bammens, D. Kuypers, H. de Jonge, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Localization, Etiology and Impact of Calcium Phosphate Deposits in Renal Allografts

E. Lerut, B. Bammens, P. Vermeersch, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Parathyroidectomy after successful kidney transplantation: a single centre study.

F. Debruyne, D. Kuypers, Y. Vanrenterghem, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Tertiary ‘Hyperphosphatoninism’ Accentuates Hypophosphatemia and Suppresses Calcitriol Levels in Renal Transplant Recipients

D. Kuypers, M. Naesens, Y. Vanrenterghem, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosis.

V. Armstrong, J. Ceuppens, B. Maes, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: Implications for drug exposure in renal allograft recipients

V. Armstrong, K. Verbeke, D. Kuypers, 2006, Clinical pharmacology and therapeutics.

Three years of experience with a 'presumed consent' legislation in Belgium: its impact on multi-organ donation in comparison with other European countries. The Leuven Collaborative Group for Transplantation.

M. Christiaens, Y. Vanrenterghem, M. Waer, 1991, Transplantation proceedings.

Three years of experience with a presumed consent legislation in Belgium : its impact on multi-organ donation in comparison with other european countries

M. Christiaens, Y. Vanrenterghem, M. Waer, 1991 .

Supported by an educational grant from A young patient with unexplained acute hepatorenal dysfunction

B. Maes, D. Kuypers, Y. Vanrenterghem, 2003 .

B. Maes, D. Kuypers, Y. Vanrenterghem, 2004, Clinical pharmacokinetics.

Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.

E. Lerut, D. Kuypers, H. de Jonge, 2009, Journal of the American Society of Nephrology : JASN.

Major Coagulation Disturbances During Fractionated Plasma Separation and Adsorption

F. Nevens, B. Bammens, P. Verhamme, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Sequential Observation of Fundus Changes in Patients with Long Standing Membranoproliferative Glomerulonephritis Type II (MPGN type II)

Y. Pirson, Y. Vanrenterghem, B. van Damme, 1991, European journal of ophthalmology.

Impact of Vascular Calcification on Corrected QT Interval at the Time of Renal Transplantation

B. Bammens, D. Kuypers, Y. Vanrenterghem, 2011, American Journal of Nephrology.

Comparison of the immunosuppressive effect of fractionated total lymphoid irradiation (TLI) vs conventional immunosuppression (CI) in renal cadaveric allotransplantation.

K. Ang, Y. Vanrenterghem, E. Van Der Schueren, 1984, Journal of immunology.

A highly sensitive liquid chromatography tandem mass spectrometry method for simultaneous quantification of midazolam, 1'-hydroxymidazolam and 4-hydroxymidazolam in human plasma.

K. Verbeke, D. Kuypers, H. de Loor, 2011, Biomedical chromatography : BMC.

Benefits and concerns of treating pre-dialysis and renal transplant patients with recombinant human erythropoietin.

Y. Vanrenterghem, J. Vanwalleghem, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study.

B. Maes, B. Bammens, D. Kuypers, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Daytime Rhythm and Treatment-Related Fluctuations of Serum Phosphorus Concentration in Dialysis Patients

Y. Vanrenterghem, B. Meijers, P. Evenepoel, 2012, American Journal of Nephrology.

Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study

E. Lerut, B. Bammens, D. Kuypers, 2010, Clinical transplantation.

Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.

B. Maes, B. Bammens, Y. Vanrenterghem, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Calcium Requirements after Parathyroidectomy in Patients with Refractory Secondary Hyperparathyroidism

B. Bammens, D. Kuypers, Y. Vanrenterghem, 2008, Nephron Clinical Practice.

Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.

B. Maes, D. Kuypers, Y. Vanrenterghem, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients.

P. Kerr, Y. Vanrenterghem, P. Bárány, 2002, Kidney international.

Acute rejection in non‐compliant renal allograft recipients: a distinct morphology

E. Lerut, E. Verbeken, D. Kuypers, 2007, Clinical transplantation.

THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTS

T. Lerut, Y. Vanrenterghem, P. Gresele, 1985, The Lancet.

Strategies to reduce or replace steroid dosing.

Y. Vanrenterghem, 1999, Transplantation proceedings.

Five-year safety and efficacy of belatacept in renal transplantation.

P. Friend, P. Halloran, J. Klempnauer, 2010, Journal of the American Society of Nephrology : JASN.

Role of prostaglandins in protein-induced glomerular hyperfiltration in normal humans.

Y. Vanrenterghem, R. Verberckmoes, L. Roels, 1988, The American journal of physiology.

A new single nephron model of focal and segmental glomerulosclerosis in the Munich-Wistar rat.

P. Steels, Y. Vanrenterghem, B. van Damme, 1994, Kidney international.

Direct podocyte damage in the single nephron leads to albuminuria in vivo.

G. Remuzzi, A. Remuzzi, C. Foglieni, 1995, Kidney international.

Active Heymann nephritis in complement component C6 deficient rats.

M. Daha, Y. Vanrenterghem, B. Hall, 1995, Kidney international.

Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis

Y. Vanrenterghem, Y. Vanrenterghem, M. Waer, 1990, The Lancet.

Effects of gastric emptying on oral mycophenolic acid pharmacokinetics in stable renal allograft recipients.

K. Verbeke, D. Kuypers, M. Naesens, 2007, British journal of clinical pharmacology.

Immunosuppression and Treatment of Rejection in Renal Transplantation

Y. Vanrenterghem, M. Waer, 1984 .

Anti-interleukin-2 receptor monoclonal antibodies in renal transplantation.

B. Maes, Y. Vanrenterghem, Y. Vanrenterghem, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Adjuvant Low‐Dose Cidofovir Therapy for BK Polyomavirus Interstitial Nephritis in Renal Transplant Recipients

L. Naesens, E. Lerut, D. Kuypers, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Stability of mycophenolic acid and glucuronide metabolites in human plasma and the impact of deproteinization methodology.

K. Verbeke, D. Kuypers, M. Naesens, 2008, Clinica chimica acta; international journal of clinical chemistry.

Acute rejection and renal allograft outcome.

Y. Vanrenterghem, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation.

E. Lerut, B. Bammens, D. Kuypers, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Balancing efficacy and toxicity of kidney transplant immunosuppression.

M. Sarwal, E. Lerut, D. Kuypers, 2009, Transplantation proceedings.

A multicenter, randomized, double-blind study comparing different FK778 doses (manitimus) with tacrolimus and steroids vs. MMF with tacrolimus and steroids in renal transplantation

J. Squifflet, M. Ostrowski, B. Krämer, 2012, BMC Nephrology.

Tacrolimus Exposure and Evolution of Renal Allograft Histology in the First Year After Transplantation

E. Lerut, Y. Vanrenterghem, D. Kuypers, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The impact of uridine diphosphate–glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single‐nucleotide polymorphisms T—275A and C—2152T on early mycophenolic acid dose‐interval exposure in de novo renal allograft recipients

S. Vermeire, D. Kuypers, M. Naesens, 2005, Clinical pharmacology and therapeutics.

Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type.

B. Maes, D. Kuypers, Y. Vanrenterghem, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The use of mycophenolate mofetil (Cellcept) in renal transplantation.

Y. Vanrenterghem, 1998, Contributions to nephrology.

An uncommon tumor in a renal graft recipient: a diagnostic and therapeutic challenge.

T. Roskams, C. Mathieu, B. Maes, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors.

C. Mathieu, B. Maes, D. Kuypers, 2001, Transplantation.

Use of NSAIDs in kidney transplantation.

Y. Vanrenterghem, P. Michielsen, 1993, Transplantation proceedings.

Immunosuppression and Treatment of Rejection

Y. Vanrenterghem, 1991 .

Hereditary C6 deficiency in a strain of PVG/c rats

M. Daha, Y. Vanrenterghem, B. Hall, 1994, Clinical and experimental immunology.

Tacrolimus Dose Requirements and CYP3A5 Genotype and the Development of Calcineurin Inhibitor-Associated Nephrotoxicity in Renal Allograft Recipients

K. Verbeke, E. Lerut, D. Kuypers, 2010, Therapeutic drug monitoring.

Long‐Term Pharmacokinetic Study of the Novel Combination of Tacrolimus and Sirolimus in De Novo Renal Allograft Recipients

B. Maes, D. Kuypers, Y. Vanrenterghem, 2003, Therapeutic drug monitoring.

Tailoring immunosuppressive therapy for renal transplant recipients

Y. Vanrenterghem, Y. Vanrenterghem, 2001, Pediatric transplantation.

High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis.

C. Verslype, Y. Vanrenterghem, S. Yap, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes.

Y. Vanrenterghem, Y. Vanrenterghem, H. Lemke, 1994, Kidney international.

A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters

B. Maes, D. Kuypers, Y. Vanrenterghem, 2001, The International journal of artificial organs.

The fate of second kidney transplant after recurrence of glomerulonephritis in the first transplant

J. Squifflet, Y. Pirson, C. Pouteil‐Noble, 1997 .

Minimization of Immunosuppressive Therapy After Renal Transplantation: Results of a Randomized Controlled Trial

J. Squifflet, J. Pascual, Y. Vanrenterghem, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Influence of SDZ RAD vs. MMF on gastric emptying in renal transplant recipients

B. Maes, B. Geypens, D. Kuypers, 2003, Clinical transplantation.

Clinical use of rapamycin in renal allograft recipients identifies its relevant toxicity profile and raises unsolved questions: a single-center experience.

D. Kuypers, Y. Vanrenterghem, A. Herelixka, 2003, Transplantation proceedings.

Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele.

P. Marynen, K. Devriendt, J. Cassiman, 1995, The Journal of clinical investigation.

Adhesions, focal sclerosis, protein crescents, and capsular lesions in membranous nephropathy

V. Desmet, R. Tardanico, Y. Vanrenterghem, 1990, The Journal of pathology.

Direct quantitation of oxidized low-density-lipoprotein (oxldl) and assessment of its pole in atherothrombosis in end-stage renal-disease (esrd) patients

D. Collen, Y. Vanrenterghem, J. Vermylen, 1995 .

Recurrent hemolytic uremic syndrome during oral contraception.

D. Hauglustaine, Y. Vanrenterghem, B. van Damme, 1981, Clinical nephrology.

Chronic renal-allograft failure - clinical overview

Y. Vanrenterghem, L. Roels, J. Peeters, 1995 .

Recurrence of light chain deposit disease after renal allograft transplantation: potential role of rituximab?

E. Lerut, D. Kuypers, Y. Vanrenterghem, 2007, Transplant international : official journal of the European Society for Organ Transplantation.

Impact of cyclosporine on chronic rejection and graft vasculopathy.

Y. Vanrenterghem, J. Peeters, 1994, Transplantation proceedings.

Post-transplant lymphoma of the pancreatic allograft in a kidney-pancreas transplant recipient: a misleading presentation.

C. Mathieu, E. Lerut, M. Lannoo, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.

F. Nevens, B. Bammens, W. Laleman, 2006, Artificial organs.

Detoxifying Capacity and Kinetics of Prometheus® – A New Extracorporeal System for the Treatment of Liver Failure

F. Nevens, B. Maes, B. Bammens, 2005, Blood Purification.

Unusual T-cell Repopulation after Autologous Stem Cell Transplantation for HIV-associated Lymphoma

D. Kuypers, Y. Vanrenterghem, P. Evenepoel, 2006 .

Drug interaction between mycophenolate mofetil and rifampin: Possible induction of uridine diphosphate‐glucuronosyltransferase

G. Verleden, D. Kuypers, M. Naesens, 2005, Clinical pharmacology and therapeutics.

A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy.

B. Maes, D. Kuypers, Y. Vanrenterghem, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Evidence in Favor of a Severely Impaired Net Intestinal Calcium Absorption in Patients with (Early-Stage) Chronic Kidney Disease

Y. Vanrenterghem, B. Meijers, P. Evenepoel, 2012, American Journal of Nephrology.

Effect of a presumed consent law on organ retrieval in Belgium.

Y. Vanrenterghem, M. Waer, L. Roels, 1990, Transplantation proceedings.

Prevalence and Management of Anemia in Renal Transplant Recipients: A European Survey

D. Abramowicz, C. Ponticelli, J. Morales, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Combined Kidney and Intestinal Transplantation in Patients With Enteric Hyperoxaluria Secondary to Short Bowel Syndrome

B. Bammens, D. Kuypers, Y. Vanrenterghem, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Cefazolin serum concentrations with fixed intravenous dosing in patients on chronic hemodialysis treatment.

B. Maes, D. Kuypers, Y. Vanrenterghem, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Risk Factors for Cardiovascular Events After Successful Renal Transplantation

B. Maes, C. Ponticelli, S. Fieuws, 2005, Transplantation.

Azathioprine hypersensitivity in a renal transplant recipient

Y. Vanrenterghem, P. Michielsen, K. Vandepitte, 1990, Transplant international : official journal of the European Society for Organ Transplantation.

C3D DEPOSITION IN PERITUBULAR CAPILLARIES INDICATES A VARIANT OF ACUTE RENAL ALLOGRAFT REJECTION CHARACTERIZED BY A WORSE CLINICAL OUTCOME

B. Maes, E. Lerut, D. Kuypers, 2003, Transplantation.

Isolated zygomycosis in a bought living unrelated kidney transplant

Y. Vanrenterghem, M. Waer, W. Coosemans, 1996, Transplant international : official journal of the European Society for Organ Transplantation.

A case of human Orf in an immunocompromised patient treated successfully with cidofovir cream

E. De Clercq, Y. Vanrenterghem, R. De vos, 2001, Journal of medical virology.

Kidney allograft tolerance in diabetic patients after total lymphoid irradiation (TLI).

K. Ang, Y. Vanrenterghem, E. Van Der Schueren, 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient.

D. Kuypers, Y. Vanrenterghem, P. Evenepoel, 2006, Transplantation.

Cytochrome P450 3A4 and P‐glycoprotein Activity and Assimilation of Tacrolimus in Transplant Patients with Persistent Diarrhea

P. Rutgeerts, B. Maes, K. Verbeke, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Chronic renal allograft function under cyclosporin treatment

Y. Vanrenterghem, J. Peeters, 1996 .

The use of an anti‐CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low‐dose tacrolimus and early withdrawal of steroids in renal transplant recipients

B. Maes, D. Kuypers, Y. Vanrenterghem, 2003, Clinical transplantation.

Renal cadaveric transplantation after total lymphoid irradiation in patients with diabetes.

R. Bouillon, K. Ang, T. Lerut, 1983, Kidney international. Supplement.

Identification of a major Leu 7/OKT 8 positive T-lymphocyte subpopulation in renal transplant patients pre-treated with total lymphoid irradiation.

J. Ceuppens, Y. Vanrenterghem, E. Van Der Schueren, 1986, Leukemia research.

Renal cadaveric transplantation in diabetics using total lymphoid irradiation or cyclosporin A

D. Hauglustaine, R. Bouillon, T. Lerut, 1988, Transplant international : official journal of the European Society for Organ Transplantation.

Renal transplantation in diabetes after total lymphoid irradiation (TLI)

R. Bouillon, K. Ang, Y. Vanrenterghem, 1983 .

'Full house' positive immunohistochemical membranoproliferative glomerulonephritis in a patient with portosystemic shunt.

B. Maes, D. Kuypers, Y. Vanrenterghem, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Drug interaction between itraconazole and sirolimus in a primary renal allograft recipient.

B. Maes, K. Desmet, D. Kuypers, 2005, Transplantation.

A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.

E. Lerut, B. Bammens, D. Kuypers, 2008, The Journal of antimicrobial chemotherapy.

The effect of mycophenolate mofetil on hepatitis B viral load in stable renal transplant recipients with chronic hepatitis B.

F. Nevens, B. Maes, D. Kuypers, 2001, Transplantation.

Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection?

E. Lerut, F. Noizat‐Pirenne, P. Rouger, 2007, Transfusion.

Pre-emptive kidney transplantation.

Y. Vanrenterghem, R. Verberckmoes, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Impact of early vesico ureteral reflux on the transplanted kidney.

B. Maes, Y. Vanrenterghem, F. Rega, 1999, Transplantation proceedings.

Post-transplant diabetes mellitus and renal function with tacrolimus: A decade of use, a decade of evidence. Foreword.

Y. Vanrenterghem, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients

K. Verbeke, D. Kuypers, Y. Vanrenterghem, 2012, Clinical pharmacology and therapeutics.

Spontaneous tendon ruptures in patients on chronic dialysis.

Y. Vanrenterghem, J. Donck, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Arterial infection following renal transplantation: successful management using transperineal femorofemoral crossover graft.

J. Duchateau, Y. Vanrenterghem, A. Lerut, 1989, Annals of vascular surgery.

Fluoroquinolones and Achilles tendinopathy in renal transplant recipients.

Y. Vanrenterghem, J. Donck, M. Segaert, 1994, Transplantation.

Acute-onset, steroid-sensitive, encapsulating peritoneal sclerosis in a renal transplant recipient.

B. Maes, D. Kuypers, Y. Vanrenterghem, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Belatacept-Based Regimens Are Associated With Improved Cardiovascular and Metabolic Risk Factors Compared With Cyclosporine in Kidney Transplant Recipients (BENEFIT and BENEFIT-EXT Studies)

H. Neumayer, P. Lang, J. Campistol, 2011, Transplantation.

Impact of new immunosuppressive agents on late graft outcome.

Y. Vanrenterghem, 1997, Kidney international. Supplement.

A simplified strategy for clinical management of late cytomegalovirus infection after oral ganciclovir prophylaxis in renal recipients.

B. Maes, D. Kuypers, Y. Vanrenterghem, 2005, The Journal of antimicrobial chemotherapy.

Transitional cell carcinoma in a renal allograft

A. Baert, R. Oyen, Y. Vanrenterghem, 1998, European Radiology.

Renal Cell Carcinoma in the Allograft: What Is the Role of Polyomavirus?

E. Lerut, D. Kuypers, M. Naesens, 2012, Case Reports in Nephrology and Dialysis.

Subclinical Peritubular Capillaritis at 3 Months Is Associated With Chronic Rejection at 1 Year

E. Lerut, D. Kuypers, M. Naesens, 2007, Transplantation.

AA amyloidosis due to chronic oxalate arthritis and vasculitis in a patient with secondary oxalosis after jejunoileal bypass surgery.

E. Lerut, B. Bammens, R. Westhovens, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

CYP3A4 and P‐Glycoprotein Activity in Healthy Controls and Transplant Patients on Cyclosporin vs. Tacrolimus vs. Sirolimus

B. Maes, K. Verbeke, Y. Vanrenterghem, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: consequences for FK506 assimilation.

B. Maes, K. Verbeke, Y. Vanrenterghem, 2005, Kidney international.

Immunologic profiles of renal allograft recipients treated with three immunosuppressive regimens, including total lymphoid irradiation, cyclosporine, or azathioprine

K. Ang, Y. Vanrenterghem, M. Waer, 1985 .

Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation.

Y. Vanrenterghem, J. Peeters, 1996, Transplantation proceedings.

Free p-cresol is associated with cardiovascular disease in hemodialysis patients.

K. Verbeke, B. Bammens, Y. Vanrenterghem, 2008, Kidney international.

Bartter’s and Gitelman’s Syndromes: From Gene to Clinic

Dirk Kuypers, P. Steels, D. Kuypers, 2004, Nephron Physiology.

Nephrology Dialysis Transplantation Renal Transplantation for End-stage Renal Disease Due to Paroxysmal Nocturnal Haemoglobinuria

B. Maes, D. Kuypers, Y. Vanrenterghem, 2022 .

Hypertensive brain stem encephalopathy in a patient with chronic renal failure.

Y. Vanrenterghem, L. Meylaerts, S. Lyra, 2006, Clinical nephrology.

The impact of acute rejection on the long-term outcome after renal transplantation

Y. Vanrenterghem, J. Peeters, 1997 .

Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.

B. Bammens, P. Verhamme, D. Kuypers, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Daclizumabof its Use in the Management of Organ Transplantation

T. Waldmann, M. Pescovitz, D. Eckhoff, 2001 .

Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?

Y. Vanrenterghem, 1999, Current opinion in nephrology and hypertension.

Approaches to improving long-term allograft outcome

Y. Vanrenterghem, 1998 .

Different evolution of trough and dose levels during the first year after transplantation for tacrolimus versus cyclosporine.

Y. Vanrenterghem, B. Maes, W. Lemahieu, 2005, Transplantation proceedings.

Alterations of CYP3A4 and P-glycoprotein activity in vivo with time in renal graft recipients.

B. Maes, Y. Vanrenterghem, W. Lemahieu, 2004, Kidney international.

In Vivo CYP3A4-Activity, CYP3A5-Genotype and Hematocrit Predict Tacrolimus Dose-Requirements and Clearance in Renal Transplant Recipients: 2026

K. Verbeke, D. Kuypers, Y. Vanrenterghem, 2012 .

Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study.

B. Maes, R. Oyen, D. Kuypers, 2004, Kidney international.

The value of tuberculin skin testing in haemodialysis patients.

B. Maes, D. Kuypers, Y. Vanrenterghem, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Transcatheter embolization of biopsy-related vascular injuries in renal allografts. Long-term technical, clinical and biochemical results.

Y. Vanrenterghem, G. Maleux, G. Wilms, 2003, Acta radiologica.

Transcatheter embolization of biopsy-related vascular injuries in renal allografts: Long-term technical, clinical and biochemical results

Y. Vanrenterghem, G. Maleux, G. Wilms, 2003 .

Steroids for deep-infection-associated glomerulonephritis: a two-edged sword.

B. Maes, Y. Vanrenterghem, B. van Damme, 1998, Nephrology, Dialysis and Transplantation.

Polyarteritis nodosa type vasculitis in a patient with familial Mediterranean fever treated with cyclosporin A

T. Roskams, Y. Vanrenterghem, M. Henckes, 1994, Transplant international : official journal of the European Society for Organ Transplantation.

Mycobacterial infection after renal transplantation in a Western population

B. Maes, Y. Vanrenterghem, W. Peetermans, 2003, Transplant infectious disease : an official journal of the Transplantation Society.

Recurrence and graft loss after kidney transplantation for henoch-schonlein purpura nephritis: a multicenter analysis.

E. Thervet, Y. Pirson, Y. Vanrenterghem, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Pseudoaneurysm complicating protocol renal transplant biopsies: case reports.

R. Oyen, D. Kuypers, Y. Vanrenterghem, 2008, Transplantation proceedings.

Treatment of chronic glomerulonephritis with a combination of indomethacin and cyclophosphamide.

Y. Vanrenterghem, R. Verberckmoes, L. Roels, 1975, Clinical nephrology.

Duplex Doppler evaluation of renal allograft dysfunction.

G. Marchal, A. Baert, Y. Vanrenterghem, 1989, Transplantation Proceedings.

Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine.

P. Rutgeerts, Y. Ghoos, B. Maes, 1999, Transplantation.

Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation.

B. Maes, D. Kuypers, Y. Vanrenterghem, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Duplex Doppler evaluation of renal allograft dysfunction: Doppler signal quantitation and pathologic correlation.

G. Marchal, Y. Vanrenterghem, M. Grieten, 1990, The Belgian Journal of Radiology.

Renal transplantation in patients with a vascular aortoiliac prosthesis.

Y. Vanrenterghem, J. Pirenne, W. Coosemans, 1999, Transplantation proceedings.

Renal transplantation onto abnormal urinary tract: ileal conduit urinary diversion.

L. Baert, B. Maes, D. Kuypers, 2001, Transplantation proceedings.

Posttransplant cardiovascular risk: impact on long-term patient survival. Introduction.

Y. Vanrenterghem, 2001, Transplantation.

Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome

B. Bammens, D. Kuypers, M. Naesens, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

Postimplantation X-ray parameters predict functional catheter problems in peritoneal dialysis.

B. Bammens, D. Kuypers, M. Naesens, 2014, Kidney international.

Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study.

Pieter Evenepoel, K. Verbeke, B. Bammens, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Evaluation of tuberculin skin testing in haemodialysis patients

B. Moor, D. Kuypers, Y. Vanrenterghem, 2002 .

Differential Effect of Diarrhea on FK506 Versus Cyclosporine A Trough Levels and Resultant Prevention of Allograft Rejection in Renal Transplant Recipients

B. Maes, D. Kuypers, Y. Vanrenterghem, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Carcinoid tumor and membranous glomerulonephritis: coincidence or malignancy-associated glomerulonephritis?

B. Maes, Y. Vanrenterghem, B. van Damme, 2002, Clinical nephrology.

Bilateral nephrectomy of the native kidneys reduces the incidence of arterial hypertension and erythrocytosis in kidney graft recipients treated with cyclosporin

M. Christiaens, Y. Vanrenterghem, M. Waer, 1992 .

Bilateral nephrectomy of the native kidneys reduces the incidence of arterial hypertension and erythrocytosis in kidney graft recipients treated with cyclosporin. Leuven Collaborative Group for Transplantation.

M. Christiaens, Y. Vanrenterghem, M. Waer, 1992, Transplant international : official journal of the European Society for Organ Transplantation.

Detoxifying Capacity and Kinetics of the Molecular Adsorbent Recycling System

F. Nevens, B. Maes, B. Bammens, 2003, Blood Purification.

The molecular adsorbent recycling system (MARS) and transmembrane transport of albumin‐bound toxins

F. Nevens, B. Bammens, A. Wilmer, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Anaemia after renal transplantation.

Y. Vanrenterghem, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Prevalence and determinants of anemia in the immediate postkidney transplant period

B. Bammens, D. Kuypers, Y. Vanrenterghem, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy.

B. Maes, D. Kuypers, Y. Vanrenterghem, 2001, Acta oto-rhino-laryngologica Belgica.

Vascular rejection with tacrolimus and potential long-term graft outcome.

Y. Vanrenterghem, 1999, Transplantation proceedings.

Combined Therapy with Atorvastatin and Calcineurin Inhibitors: No Interactions with Tacrolimus

Y Vanrenterghem, A. Åsberg, K. Verbeke, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate.

B. Maes, D. Kuypers, Y. Vanrenterghem, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.

B. Maes, D. Kuypers, Y. Vanrenterghem, 2002, Transplantation proceedings.

Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients.

P. de Keyser, Y. Vanrenterghem, M. Waer, 1988, Transplantation proceedings.

A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients.

D. Kuypers, H. de Jonge, M. Naesens, 2010, Clinical therapeutics.

Another devastating complication of the Schnitzler syndrome: AA amyloidosis

B. Bammens, D. Kuypers, Y. Vanrenterghem, 2007, The British journal of dermatology.

Renal cortical nephrocalcinosis

D. Kuypers, Y. Vanrenterghem, G. Verswijvel, 2000 .

Crescentic glomerulonephritis complicating the course of a hypocomplementemic urticarial vasculitis.

B. Maes, D. Kuypers, Y. Vanrenterghem, 2000, Clinical Nephrology.

Prophylaxis of cytomegalovirus infection in renal transplantation.

D. Kuypers, Y. Vanrenterghem, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

New-onset anaemia following kidney transplantation.

G. Verhoef, Y. Vanrenterghem, T. Messiaen, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Role of acute rejection in chronic rejection.

Y. Vanrenterghem, 1998, Transplantation proceedings.

The use of Mycophenolate Mofetil (Cellcept) in renal transplantation.

Y. Vanrenterghem, 1997, Nephron.

β2M-AMYLOIDOSIS AND GASTROINTESTINAL BLEEDING AFTER RENAL TRANSPLANTATION

T. Lodewyckx, B. Maes, E. Lerut, 2003 .

Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test.

Y Vanrenterghem, P. Rutgeerts, Y. Ghoos, 2003, American journal of physiology. Gastrointestinal and liver physiology.

Missense mutation and hexanucleotide duplication in the PAX2 gene in two unrelated families with renal-coloboma syndrome (MIM 120330)

M. Eccles, K. Devriendt, J. Fryns, 1998, Human Genetics.

OESTROGEN CONTAINING ORAL CONTRACEPTIVES, DECREASED PROSTACYCLIN PRODUCTION, AND HAEMOLYTIC URAEMIC SYNDROME

D. Hauglustaine, Y. Vanrenterghem, P. Michielsen, 1981, The Lancet.